ALPS Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-57,751
Closed -$161K 1038
2023
Q1
$161K Buy
57,751
+1,139
+2% +$3.25K ﹤0.01% 989
2022
Q4
$195K Buy
+56,612
New +$162K ﹤0.01% 1002
2022
Q2
Sell
-74,723
Closed -$308K 1095
2022
Q1
$308K Sell
74,723
-3,955
-5% -$21K ﹤0.01% 762
2021
Q4
$1.01M Buy
+78,678
New +$871K 0.01% 356

Other funds holding GRTS

ALPS Advisors's GRTS Position: Q2 2023 in Review

ALPS Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2023, closing a stake of 57,751 shares — an estimated $161K sold.

ALPS Advisors first reported a position in GRTS in Q4 2021 and held it in 4 quarters. The position peaked at $1.01M in Q4 2021. 88 funds tracked by Wall St. Rank hold GRTS as of Q2 2023.

  • ALPS Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • ALPS Advisors sold 57,751 Gritstone bio, Inc. Common Stock shares in Q2 2023, an estimated $161K.
  • ALPS Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • ALPS Advisors's Gritstone bio, Inc. Common Stock position peaked at $1.01M in Q4 2021.
  • 88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2023.

Based on ALPS Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.